Direct line: 1300 987 995
Feb 20 (Reuters) - Rhinomed Ltd
* Raises A$2.5 million to accelerate drug delivery program
* Placement of 60 million new fully paid ordinary shares at an issue price of
A$0.042 per share
* "Funds raised enables the company to accelerate the drug delivery program
focused on the delivery of sumatriptan using the breatheassist technology
platform"
* Source text for Eikon
((For more news, please click here